ESSA Pharma Inc (EPIX)

NASDAQ
Currency in USD
1.67
-0.03(-1.76%)
Closed·
After Hours
1.66-0.01(-0.60%)
·
EPIX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
EPIX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.661.70
52 wk Range
1.407.88
Key Statistics
Edit
Prev. Close
1.7
Open
1.68
Day's Range
1.66-1.7
52 wk Range
1.4-7.88
Volume
39.1K
Average Volume (3m)
154.13K
1-Year Change
-63.93%
Book Value / Share
2.56
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
EPIX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
1.74
Upside
+4.11%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

ESSA Pharma Inc News & Analysis

Show more

ESSA Pharma Company Profile

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company was incorporated in 2009 and is headquartered in Vancouver, Canada.

Compare EPIX to Peers and Sector

Metrics to compare
EPIX
Peers
Sector
Relationship
P/E Ratio
−2.6x−2.4x−0.5x
PEG Ratio
1.210.000.00
Price/Book
0.7x1.8x2.6x
Price / LTM Sales
-4.2x3.1x
Upside (Analyst Target)
2.1%330.8%50.4%
Fair Value Upside
Unlock20.4%8.7%Unlock

Analyst Ratings

0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 1.74
(+4.11% Upside)

Earnings

Latest Release
May 08, 2025
EPS / Forecast
-0.14 / -0.15
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

EPIX Income Statement

FAQ

What Is the ESSA Pharma (EPIX) Stock Price Today?

The ESSA Pharma stock price today is 1.67.

What Stock Exchange Does ESSA Pharma Trade On?

ESSA Pharma is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for ESSA Pharma?

The stock symbol for ESSA Pharma is "EPIX."

What Is the ESSA Pharma Market Cap?

As of today, ESSA Pharma market cap is 74.13M.

What Is ESSA Pharma's Earnings Per Share (TTM)?

The ESSA Pharma EPS (TTM) is -0.64.

When Is the Next ESSA Pharma Earnings Date?

ESSA Pharma will release its next earnings report on 05 Aug 2025.

From a Technical Analysis Perspective, Is EPIX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has ESSA Pharma Stock Split?

ESSA Pharma has split 1 times.

How Many Employees Does ESSA Pharma Have?

ESSA Pharma has 35 employees.

What is the current trading status of ESSA Pharma (EPIX)?

As of 14 Jun 2025, ESSA Pharma (EPIX) is trading at a price of 1.67, with a previous close of 1.70. The stock has fluctuated within a day range of 1.66 to 1.70, while its 52-week range spans from 1.40 to 7.88.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.